StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 15/3029% above fair value
$515.02−5.64 (-1.08%)

Close on Nov 20, 2026Market cap $130.54BP/E 30.0Yield –

Vertex Pharmaceuticals Total current assets by Quarter

Total current assets ($M) ($M)

Vertex Pharmaceuticals Total current assets: $12,544M in Q2 2026, up 20.3% from a year earlier.

Latest, Q2 2026
12,544
Period ended Jun 30, 2026
Change on a year earlier
+20.3%
10,428 in Q2 2025
History
67 quarters
Since Q4 2009
Sources
65
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-04) ↗

Reported in Form 10-Q / 10-K (DB).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal current assets ($M) ($M)Year on yearSource
Q2 2026Jun 30, 202612,544+20.3%Form 10-Q (filed 2026-08-04) ↗
Q1 2026Mar 31, 202611,730+17.2%Form 10-Q (filed 2026-05-05) ↗
Q4 2025Dec 31, 202511,201+16.7%Form 10-K (filed 2026-02-13) ↗
Q3 2025Sep 30, 202510,570+7.8%Form 10-Q (filed 2025-11-04) ↗
Q2 2025Jun 30, 202510,428+16.6%Form 10-Q (filed 2025-08-05) ↗
Q1 2025Mar 31, 202510,009-24.7%Form 10-Q (filed 2025-05-06) ↗
Q4 2024Dec 31, 20249,596-32.2%Form 10-K (filed 2025-02-13) ↗
Q3 2024Sep 30, 20249,804-33.3%Form 10-Q (filed 2024-11-05) ↗
Q2 2024Jun 30, 20248,942-35.5%Form 10-Q (filed 2024-08-02) ↗
Q1 2024Mar 31, 202413,289+2.5%Form 10-Q (filed 2024-05-07) ↗
Q4 2023Dec 31, 202314,144+6.9%Form 10-K (filed 2024-02-15) ↗
Q3 2023Sep 30, 202314,696+19.8%Form 10-Q (filed 2023-11-07) ↗
Q2 2023Jun 30, 202313,873+20.6%Form 10-Q (filed 2023-08-02) ↗
Q1 2023Mar 31, 202312,966+25.1%Form 10-Q (filed 2023-05-02) ↗
Q4 2022Dec 31, 202213,235+38.4%Form 10-K (filed 2023-02-10) ↗
Q3 2022Sep 30, 202212,271+38.6%Form 10-Q (filed 2022-10-28) ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals Total current assets ($M), quarterly Q4 2009–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/fs-ca

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.

See a number that looks wrong?